ACADIA Pharmaceuticals: Advancing On Several Fronts

Live Chat on The Biotech Forum has been dominated by discussion of covered call opportunities in recent quarters. To see what I and the other season biotech investors are targeting as trading ideas real-time, just initiate your two-week no obligation free trial into The Biotech Forum by clicking HERE .Today, we are circling back to ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ) . I touched base on this mid-cap biopharma early in March. However, there has been a torrent of new data points to analyze since that ...